How does SURAKSHA's PE Ratio compare to its peers?

SURAKSHA is expensive based on its Price-To-Earnings Ratio (89.7x) compared to the peer average (60.3x).

How does SURAKSHA's PE Ratio compare vs other companies in the IN Healthcare Industry?

SURAKSHA is expensive based on its Price-To-Earnings Ratio (89.7x) compared to the Indian Healthcare industry average (44.8x).

What is SURAKSHA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate SURAKSHA's Price-To-Earnings Fair Ratio for valuation analysis.

What is the Fair Price of SURAKSHA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

SURAKSHA (₹407.05) is trading above our estimate of [[fair value]] (₹124.74)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

SURAKSHA Stock Overview

Operates a chain of diagnostic centers in India. More details

SURAKSHA fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	3/6
Financial Health	4/6
Dividends	0/6

Rewards

Earnings grew by 262.6% over the past year

Risk Analysis

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Suraksha Diagnostic Limited Competitors

Dr. Agarwal's Eye Hospital

BSE:526783

₹26.7b

Krsnaa Diagnostics

NSEI:KRSNAA

₹29.7b

Thyrocare Technologies

BSE:539871

₹52.6b

Vijaya Diagnostic Centre

NSEI:VIJAYA

₹109.9b

Price History & Performance

Summary of share price highs, lows and changes for Suraksha Diagnostic
Historical stock prices
Current Share Price	₹407.05
52 Week High	₹449.00
52 Week Low	₹398.35
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-2.44%

Recent updates

Shareholder Returns

	SURAKSHA	IN Healthcare	IN Market
7D	-2.6%	0.4%	-0.9%
1Y	n/a	43.5%	22.5%

Return vs Industry: Insufficient data to determine how SURAKSHA performed against the Indian Healthcare industry.

Return vs Market: Insufficient data to determine how SURAKSHA performed against the Indian Market.

Price Volatility

Is SURAKSHA's price volatile compared to industry and market?
SURAKSHA volatility
SURAKSHA Average Weekly Movement	n/a
Healthcare Industry Average Movement	5.8%
Market Average Movement	6.2%
10% most volatile stocks in IN Market	9.1%
10% least volatile stocks in IN Market	4.1%

Stable Share Price: SURAKSHA's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: Insufficient data to determine SURAKSHA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1992	1,175	Ritu Mittal	www.surakshanet.com

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing; radiology testing, such as magnetic resonance imaging (MRI), computed tomography (CT) scan, dual-energy X-ray absorptiometry (DEXA) scan, interventional ultrasonography, CT guided biopsy, and X-Ray imaging services; and medical consultation services. The company was founded in 1992 and is based in based in Kolkata, India.

Suraksha Diagnostic Limited Fundamentals Summary

How do Suraksha Diagnostic's earnings and revenue compare to its market cap?
SURAKSHA fundamental statistics
Market cap	₹21.20b
Earnings (TTM)	₹236.26m
Revenue (TTM)	₹2.19b

89.7x

P/E Ratio

9.7x

P/S Ratio

Is SURAKSHA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SURAKSHA income statement (TTM)
Revenue	₹2.19b
Cost of Revenue	₹354.01m
Gross Profit	₹1.83b
Other Expenses	₹1.60b
Earnings	₹236.26m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Dec 20, 2024

Earnings per share (EPS)	4.54
Gross Margin	83.81%
Net Profit Margin	10.80%
Debt/Equity Ratio	4.8%

How did SURAKSHA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/18 21:19
End of Day Share Price	2024/12/18 00:00
Earnings	2024/03/31
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Suraksha Diagnostic Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

Suraksha Diagnostic NSEI:SURAKSHA Stock Report